Search research articles
Contact Us
Filters
Showing results (61-70 of 110) with videos related to
Page
of 11
Sort By:
Journal of Endocrinological Investigation
|
July 2, 1998
Pituitary apoplexy in acromegaly, a long-term follow-up study in two patients
F Roelfsema, G van den Berg, H van Dulken, et al.
Japanese Journal of Clinical Oncology
|
February 1, 1996
Acromegaly caused by growth hormone-relating hormone in a patient with multiple endocrine neoplasia type I
S W Liu, C J van de Velde, J M Heslinga, et al.
Clinical Endocrinology
|
March 1, 1979
Exchange of triiodothyronine derived from thyroxine with circulating triiodothyronine as studied in the rat
M J Obregon, F Roelfsema, G Morreale de Escobar, et al.
Clinical Endocrinology
|
December 1, 1985
Glucagon-stimulated plasma C-peptide and insulin levels in active and non-active acromegalics
F Roelfsema, M Frölich, P H Geelhoed-Duyvestijn, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
April 13, 1996
[Tumors outside of the central nervous system in Von Hippel-Lindau disease]
G A Veltman, A B Arntzenius, J C Oosterwijk, et al.
Clinical Endocrinology
|
January 1, 1979
The influence of bromocriptine on serum levels of growth hormone and other pituitary hormones and its metabolic effects in active acromegaly
F Roelfsema, B M Goslings, M Frölich, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 12, 2002
Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans
S W Kok, A E Meinders, S Overeem, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
June 3, 2004
Pulsatile LH release is diminished, whereas FSH secretion is normal, in hypocretin-deficient narcoleptic men
S W Kok, F Roelfsema, S Overeem, et al.
European Journal of Endocrinology
|
April 27, 1999
Increased episodic release and disorderliness of prolactin secretion in both micro- and macroprolactinomas
R Groote Veldman, G van den Berg, S M Pincus, et al.
Clinical Endocrinology
|
January 1, 1988
Plasma growth hormone half-life after selective removal of adenoma in acromegalics determines the outcome of surgery
F Roelfsema, D van der Heide, P J Lowry, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 110) with videos related to
Sort By:
Page
of 11
Journal of Endocrinological Investigation
|
July 2, 1998
Pituitary apoplexy in acromegaly, a long-term follow-up study in two patients
F Roelfsema, G van den Berg, H van Dulken, et al.
Japanese Journal of Clinical Oncology
|
February 1, 1996
Acromegaly caused by growth hormone-relating hormone in a patient with multiple endocrine neoplasia type I
S W Liu, C J van de Velde, J M Heslinga, et al.
Clinical Endocrinology
|
March 1, 1979
Exchange of triiodothyronine derived from thyroxine with circulating triiodothyronine as studied in the rat
M J Obregon, F Roelfsema, G Morreale de Escobar, et al.
Clinical Endocrinology
|
December 1, 1985
Glucagon-stimulated plasma C-peptide and insulin levels in active and non-active acromegalics
F Roelfsema, M Frölich, P H Geelhoed-Duyvestijn, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
April 13, 1996
[Tumors outside of the central nervous system in Von Hippel-Lindau disease]
G A Veltman, A B Arntzenius, J C Oosterwijk, et al.
Clinical Endocrinology
|
January 1, 1979
The influence of bromocriptine on serum levels of growth hormone and other pituitary hormones and its metabolic effects in active acromegaly
F Roelfsema, B M Goslings, M Frölich, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 12, 2002
Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans
S W Kok, A E Meinders, S Overeem, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
June 3, 2004
Pulsatile LH release is diminished, whereas FSH secretion is normal, in hypocretin-deficient narcoleptic men
S W Kok, F Roelfsema, S Overeem, et al.
European Journal of Endocrinology
|
April 27, 1999
Increased episodic release and disorderliness of prolactin secretion in both micro- and macroprolactinomas
R Groote Veldman, G van den Berg, S M Pincus, et al.
Clinical Endocrinology
|
January 1, 1988
Plasma growth hormone half-life after selective removal of adenoma in acromegalics determines the outcome of surgery
F Roelfsema, D van der Heide, P J Lowry, et al.
Page
of 11